Dopaminergic medication affects choice bias in Parkinson’s disease
Objective: Assess dopaminergic effects on choice bias in Parkinson's disease (PD). Background: Bradykinesia, rigidity and resting tremor are the core symptoms of PD, but many…Cognitive profile of Filipino patients with X-linked dystonia parkinsonism
Objective: This study aims to provide a quantitative and qualitative description of the neuropsychological profile of patients diagnosed with X-linked dystonia-parkinsonism (XDP) given in a…Optic nerve integration as a visuospatial cognitive predictor in Parkinson’s disease
Objective: To explore the microstructural integrity of the optic nerve and its role as a cognitive predictor in patients with de novo Parkinson's disease (PD)…Performance in Montreal cognitive assessment and functional independence in Parkinsonian with normal mini-mental state examination
Objective: 1. to describe the performance in Montreal Cognitive Assessment (MoCA) in a sample of Parkinson's disease patients with normal Mini-Mental State Examination (MMSE). 2.…Unilateral subthalamotomy in Parkinson´s disease: Cognitive and neuropsychiatric effects and correlation with lesion size
Objective: To assess cognitive and neuropsychiatric effects of unilateral subthalamotomy in Parkinson´s disease (PD) and their correlation with lesion size. Background: Surgery for treatment of…Apolipoprotein E genotypes in Brazilian patients with Parkinson’s disease and their correlation with cognitive performance assessed by MoCA
Objective: Analysing the relationship between the polymorphisms of ApoE gene and cognitive performance of patients with Parkinson's disease. Background: Cognitive impairment is a common clinical…Visual hallucinations and executive dysfunction in Charles Bonnet syndrome: Preliminary findings from SHAPED
Objective: To establish whether frontal cognitive deficits associated with visual hallucinations in Parkinson's disease (PD) are also present in patients with Charles Bonnet Syndrome (CBS).…Systematic literature review of quetiapine for hallucinosis / psychosis in Parkinson’s disease (PD)
Objective: To conduct a systematic review to evaluate the efficacy, safety, and dosing range of quetiapine for the treatment for hallucinosis / psychosis in patients…Is there any relationship between olfactory dysfunction and memory disorder?
Objective: To clarify the relationship between non-motor symptoms and memory disorder in 160 cases with PD without cognitive decline in our out-patients clinic. Background: Both…The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson’s disease
Objective: We investigated the relationship between olfactory impairment, REM sleep behavior disorders (RBD), initial cognitive performance and motor phenotype in Parkinson's disease (PD). Background: Olfactory…
- « Previous Page
- 1
- …
- 105
- 106
- 107
- 108
- 109
- …
- 117
- Next Page »